de Langen, Adrianus J.
Jebbink, M.
Hashemi, Sayed M. S.
Kuiper, Justine L.
de Bruin-Visser, J.
Monkhorst, Kim
Thunnissen, Erik
Smit, Egbert F.
Funding for this research was provided by:
Roche (Drug support for trastuzumab)
Article History
Received: 13 March 2018
Revised: 2 July 2018
Accepted: 4 July 2018
First Online: 31 July 2018
Competing interests
: The authors declare no competing interests.
: The trial has been approved by the local ethics committee of the VU University Medical Center and registered on clinicaltrials.gov under the number NCT02226757. The study was performed in accordance with the Declaration of Helsinki. Consent of patients was obtained before entering the study.
: The datasets generated during and/or analyzed during the current study are on file with the corresponding author and information can be requested by contacting the corresponding author.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).